← Back
$TEVA All transactions

TEVA PHARMACEUTICAL INDUSTRIES LTD

▼ SELL

$ Value

$753K

Shares

30,000

Price

$25

Filed

Nov 18

Insider

Name

Fox Christine

Title

EVP, Head of U.S. Commercial

CIK

0001998173

Roles

Officer

Transaction Details

Transaction Date

2025-11-14

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

28,384

Footnotes

The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Filing Info

Accession No.

0001193125-25-286134

Form Type

4

Issuer CIK

0000818686

Fox Christine's History

Date Ticker Type Value
2026-03-05 TEVA M
2026-03-05 TEVA $251K
2026-03-05 TEVA M $0
2026-03-04 TEVA M
2026-03-04 TEVA $295K
2026-03-04 TEVA M $0
2026-03-04 TEVA A $0
2025-11-20 TEVA M
2025-11-20 TEVA $700K
2025-11-20 TEVA M $0

Other Insiders at TEVA (90d)

Insider Bought Sold Last
Francis Richard D
President and CEO
$31.1M 2026-03-05
Sabag Mark
See "Remarks"
2026-03-05
Daniell Richard
EVP, Europe Commercial
$7.7M 2026-03-05
Daniell Richard
Exec. VP, European Commercial
2026-01-27
Kalif Eliyahu Sharon
EVP, Chief Financial Officer
$11.6M 2026-03-05
Weiss Amir
Chief Accounting Officer
2026-03-05
Hughes Eric A
See "Remarks"
$3.3M 2026-03-05
Fox Christine
EVP, U.S. Commercial
$546K 2026-03-05
Shields Matthew
EVP, Global Operations
$548K 2026-03-05
Jover Placid
See "Remarks"
$448K 2026-03-05
Lippman Evan
EVP, Business Development
2026-03-04
Savage Brian
Interim Chief Legal Officer
$164K 2026-03-05